Capricor Therapeutics (NASDAQ:CAPR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Capricor Therapeutics (CAPR) operate in?

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Capricor Therapeutics Stock (NASDAQ: CAPR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 3.05M
Day Range	- - -
52 Wk Range	2.87 - 23.40
Market Cap	$859.38M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	13.17%
Days to Cover	2.75

Recent News

Why Capricor Therapeutics (CAPR) Shares Are Trading Lower

Capricor Therapeutics shares are trading lower by 2.7% during Thursday's session. The company earlier commenced its public offering of common stock.

Henry Khederian

CSX Posts Weak Earnings, Joins Lucid Group, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years

Capricor Therapeutics announced promising 3-year results from its HOPE-2 extension study for deramiocel in treating Duchenne muscular dystrophy, showing significant cardiac and motor function improvements.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 3.05M
Day Range	- - -
52 Wk Range	2.87 - 23.40
Market Cap	$859.38M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	13.17%
Days to Cover	2.75

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Capricor Therapeutics (CAPR) stock?

You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.

View our list of the best stock brokerages

Who are Capricor Therapeutics (CAPR) competitors?

Other companies in Capricor Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Upstream Bio (NASDAQ:UPB).

What is the forecast, or price target, for Capricor Therapeutics (CAPR) stock?

Capricor Therapeutics has a consensus price target of $39.29.

What is the current price for Capricor Therapeutics (CAPR)?

The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $18.9 last updated November 20, 2024 at 6:43 PM EST.

Does Capricor Therapeutics (CAPR) pay a dividend?

There are no upcoming dividends for Capricor Therapeutics.

When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?

Capricor Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Capricor Therapeutics (CAPR) going to split?

There is no upcoming split for Capricor Therapeutics.

What sector and industry does Capricor Therapeutics (CAPR) operate in?

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Capricor Therapeutics

Capricor Therapeutics (CAPR) Forecast